Giant prolactinomas presenting as skull base tumors

Surg Neurol. 2002 Feb;57(2):99-103; discussion 103-4. doi: 10.1016/s0090-3019(01)00697-8.

Abstract

Background: Prolactinomas invading the skull base are rare, and could easily be confused with skull base tumors of nonpituitary origin.

Case description: We report a series of 4 cases of giant prolactinomas invading the skull base and presenting with atypical symptoms. Case 1 presented with a short history of headache and nasal obstruction. Case 2 presented with progressive hypoacusia, dizziness, and ophthalmoplegia. In Case 3, the patient developed rapid progressive visual failure and psychiatric symptoms. Case 4 presented with a 1-year history of headache and retrorbital pain. The diagnosis of prolactinoma was made on the basis of tumor immunohistochemistry and/or high plasma prolactin levels (range from 650-6,500 ng/mL). Medical treatment with the dopamine agonist cabergoline was given; it was effective in normalizing prolactin levels and inducing tumor shrinkage.

Conclusion: Prolactin levels should be measured in all large skull base tumors involving the pituitary region before any surgery or inappropriate radiotherapy is performed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cabergoline
  • Diagnosis, Differential
  • Dopamine Agonists / therapeutic use
  • Ergolines / therapeutic use
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Pituitary Neoplasms / blood
  • Pituitary Neoplasms / diagnosis*
  • Pituitary Neoplasms / drug therapy
  • Pituitary Neoplasms / pathology
  • Prolactin / blood
  • Prolactinoma / blood
  • Prolactinoma / diagnosis*
  • Prolactinoma / drug therapy
  • Prolactinoma / pathology
  • Skull Base Neoplasms / diagnosis*

Substances

  • Dopamine Agonists
  • Ergolines
  • Prolactin
  • Cabergoline